Citation: Lijun Li, Chenliang Guo, Yuelin Fang, Zijian Cheng, Yaowei Li, Zhangyu Wang, Dian Cai, Yuqi Xu, Wenqi Liu, Shouwei Ma, Xinxin Zhang. Deformable hyaluronic acid niosomes overcome multi-barriers for improved ergothioneine transdermal delivery against UV-induced skin damage[J]. Chinese Chemical Letters, ;2025, 36(11): 110839. doi: 10.1016/j.cclet.2025.110839 shu

Deformable hyaluronic acid niosomes overcome multi-barriers for improved ergothioneine transdermal delivery against UV-induced skin damage

Lijun Li ^{a, b, 1} ,
Chenliang Guo ^{d, 1} ,
Yuelin Fang ^c ,
Zijian Cheng ^{a, b} ,
Yaowei Li ^e ,
Zhangyu Wang ^{a, b} ,
Dian Cai ^{a, b} ,
Yuqi Xu ^{a, b} ,
Wenqi Liu ^c ,
Shouwei Ma ^{d, *,} ,
Xinxin Zhang ^{a, b, c, e, *,}

a.
Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
b.
University of Chinese Academy of Sciences, Beijing 100049, China
c.
Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai 264117, China
d.
Bloomage Biotechnology Corporation Limited, Shanghai 201304, China
e.
School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China

mashouwei306@163.com

xinxinzhang@simm.ac.cn

Received Date: 13 November 2024
Revised Date: 5 January 2025
Accepted Date: 9 January 2025
Available Online: 9 January 2025

Figures(6)

The complex skin structure and insufficient intracellular entrapment limit the therapeutic effects of active substances, therefore appealing to a more effective transdermal drug delivery system design. Herein, a hyaluronic acid (HA) modified steareth-2-based niosomes (HA-nio) with satisfactory deformability and targeting properties was designed for ergothioneine (EGT) (EGT@HA-nio) against ultraviolet (UV)-induced skin damage. The unique composition allows EGT@HA-nio to exhibit high mechanical softness, making it deformable to pass through the stratum corneum by the intercellular space without rupture. For further intracellular delivery, HA modification enables EGT to target human dermal cells (HDFs) with increased distribution in mitochondria without the restriction of specific EGT transporter-organic cation transporter 1 (OCTN-1). Benefiting from the above properties, an adequate amount of EGT in the active form was accumulated in the desired cellular sites, alleviating UV-radiation-induced reactive oxygen species (ROS) generation, inflammatory factor release, DNA damage, and mitochondrial dysfunction. The in vivo experimental results show that EGT@HA-nio could significantly decrease collagen degradation, restore epidermal thickness and morphology to healthy levels, and effectively prevent UV-induced skin damage. With the ability to penetrate biological barriers and deliver drugs, HA-nio may promote the development of inadequate drug penetration disease treatment including skin diseases, cancers, and bacterial infections.
- Transdermal delivery,
- Ergothioneine,
- Deformability,
- Niosomes,
- UV-induced skin damage
1. [1]
  J. Lee, G.W. Hwang, B.S. Lee, et al., ACS Nano 18 (2024) 5311–5321.
2. [2]
  X. Hu, N. Cheng, J. Zhao, et al., Asian J. Pharm. Sci. 14 (2019) 305–312.
3. [3]
  K.T.M. Tran, T.D. Gavitt, N.J. Farrell, et al., Nat. Biomed. Eng. 5 (2021) 998–1007.
4. [4]
  C.C. Yu, A. Shah, N. Amiri, et al., Adv. Mater. 35 (2023) e2300066. doi: 10.1002/adma.202300066
5. [5]
  X. Hu, J. Yu, L. Sun, et al., Chin. Chem. Lett. 35 (2024) 109466. doi: 10.1016/j.cclet.2023.109466
6. [6]
  Y. Zhou, D. Gao, Y. Wang, et al., Chin. Chem. Lett. 35 (2024) 108967. doi: 10.1016/j.cclet.2023.108967
7. [7]
  Y. Fang, G. Li, C. Huang, et al., Int. J. Biol. Macromol. 229 (2023) 123–135. doi: 10.1016/j.ijbiomac.2022.12.046
8. [8]
  Y. Fang, T. Nie, G. Li, et al., Chem. Eng. J. 480 (2024) 147930. doi: 10.1016/j.cej.2023.147930
9. [9]
  X. Zhang, M. Zhao, N. Cao, et al., Biomater. Sci. 8 (2020) 1885–1896. doi: 10.1039/c9bm01927h
10. [10]
  S. Zhang, P. Xin, Q. Ou, et al., J. Mater. Chem. B 6 (2023) 6723–6730. doi: 10.3233/jifs-221903
11. [11]
  C. Wiraja, Y. Zhu, D.C.S. Lio, et al., Nat. Commun. 10 (2019) 1147. doi: 10.1038/s41467-019-09029-9
12. [12]
  Z. Lu, S. Du, J. Li, et al., Adv. Mater. 35 (2023) e2303388. doi: 10.1002/adma.202303388
13. [13]
  Y. Yang, L. Xu, D. Jiang, et al., Adv. Funct. Mater. 31 (2021) 2104092. doi: 10.1002/adfm.202104092
14. [14]
  T.H. Truong, K.P. Alcantara, B.P.I. Bulatao, et al., Carbohydr. Polym. 288 (2022) 119401. doi: 10.1016/j.carbpol.2022.119401
15. [15]
  N. Loza-Rodríguez, A. Millán-Sánchez, M. Mallandrich, et al., Pharmaceutics 16 (2024) 1187. doi: 10.3390/pharmaceutics16091187
16. [16]
  A. Garcês, M.H. Amaral, J.M. Sousa Lobo, et al., Eur. J. Pharm. Sci. 112 (2018) 159–167. doi: 10.1016/j.ejps.2017.11.023
17. [17]
  P. Gurnani, C. Sanchez-Cano, H. Xandri-Monje, et al., Small 18 (2022) 2203070. doi: 10.1002/smll.202203070
18. [18]
  X. Zhou, Y. Hao, L. Yuan, et al., Chin. Chem. Lett. 29 (2018) 1713–1724. doi: 10.1016/j.cclet.2018.10.037
19. [19]
  S. Polaka, V. Makwana, N. Vasdev, et al., J. Control. Release 345 (2022) 385–404. doi: 10.1016/j.jconrel.2022.03.013
20. [20]
  L. Chen, L. Zhang, X. Ye, et al., Protein Cell 15 (2024) 191–206. doi: 10.1093/procel/pwad048
21. [21]
  D. Gründemann, S. Harlfinger, S. Golz, et al., Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 5256–5261. doi: 10.1073/pnas.0408624102
22. [22]
  S.A.T. Opatha, V. Titapiwatanakun, R. Chutoprapat, Pharmaceutics 12 (2020) 855. doi: 10.3390/pharmaceutics12090855
23. [23]
  E. Bárány, M. Lindberg, M. Lodén, Int. J. Pharm. 195 (2000) 189–195. doi: 10.1016/S0378-5173(99)00388-9
24. [24]
  S. Ghanbarzadeh, A. Khorrami, S. Arami, Drug Deliv. 22 (2015) 1071–1077. doi: 10.3109/10717544.2013.873837
25. [25]
  M.A. Wagdi, A. Salama, M.A. El-Liethy, et al., J. Drug Deliv. Sci. Technol. 84 (2023) 104456. doi: 10.1016/j.jddst.2023.104456
26. [26]
  B. Baroli, J. Pharm. Sci. 99 (2010) 21–50. doi: 10.1002/jps.21817
27. [27]
  C. Ni, Z. Zhang, Y. Wang, et al., J. Control. Release 357 (2023) 432–443. doi: 10.1016/j.jconrel.2023.03.049
28. [28]
  H.M. Liu, W. Tang, X.Y. Wang, et al., Molecules 28 (2023) 1648. doi: 10.3390/molecules28041648
29. [29]
  L. Li, C. Liu, J. Fu, et al., Int. J. Biol. Macromol. 243 (2023) 125239. doi: 10.1016/j.ijbiomac.2023.125239
30. [30]
  J.J. Rennick, A.P.R. Johnston, R.G. Parton, Nat. Nanotechnol. 16 (2021) 266–276. doi: 10.1038/s41565-021-00858-8
31. [31]
  A. Kuzumi, A. Yoshizaki-Ogawa, T. Fukasawa, et al., Am. J. Clin. Dermatol. 25 (2024) 951–966. doi: 10.1007/s40257-024-00891-y
32. [32]
  W. Wen, J. Chen, L. Ding, et al., Arch. Biochem. Biophys. 657 (2018) 31–40. doi: 10.1016/j.abb.2018.09.007
33. [33]
  L. Li, Y. Wang, Y. Xu, et al., J. Control. Release 371 (2024) 298–312. doi: 10.1016/j.jconrel.2024.05.048
34. [34]
  Y. Tian, H. Shi, D. Zhang, et al., J. Control. Release 364 (2023) 618–631. doi: 10.1016/j.jconrel.2023.10.018
35. [35]
  Y. You, Y. Tian, Z. Yang, et al., Nat. Biomed. Eng. 7 (2023) 887–900. doi: 10.1038/s41551-022-00989-w
36. [36]
  K. Yao, Y. Peng, Q. Tang, et al., Int. J. Nanomed. 19 (2024) 9161–9174. doi: 10.2147/ijn.s446090
37. [37]
  H. Zhang, X. Xiao, L. Wang, et al., Sig. Transduc. Target. Ther. 9 (2024) 294. doi: 10.1109/cyberscitech64112.2024.00053
38. [38]
  J.S. Choi, W.L. Cho, Y.J. Choi, et al., J. Extracell. Vesicles 8 (2019) 1565885. doi: 10.1080/20013078.2019.1565885
39. [39]
  Z. Yan, T. Kavanagh, R. da Silva Harrabi, et al., Adv. Funct. Mater. 34 (2024) 2309711. doi: 10.1002/adfm.202309711
1. [1]
  Linghui Zou , Meng Cheng , Kaili Hu , Jianfang Feng , Liangxing Tu . Vesicular drug delivery systems for oral absorption enhancement. Chinese Chemical Letters, 2024, 35(7): 109129-. doi: 10.1016/j.cclet.2023.109129
2. [2]
  Bing Xie , Qi Jiang , Fang Zhu , Yaoyao Lai , Yueming Zhao , Wei He , Pei Yang . Transdermal delivery of amphotericin B using deep eutectic solvents for antifungal therapy. Chinese Chemical Letters, 2025, 36(5): 110508-. doi: 10.1016/j.cclet.2024.110508
3. [3]
  Xuebing Jiang , Siyi Wang , Li Zhang , Xian Jiang , Maling Gou . Lidocaine hydrochloride loaded isomaltulose microneedles for efficient local anesthesia of the skin. Chinese Chemical Letters, 2024, 35(4): 108686-. doi: 10.1016/j.cclet.2023.108686
4. [4]
  Dexuan Xiao , Tianyu Chen , Tianxu Zhang , Sirong Shi , Mei Zhang , Xin Qin , Yunkun Liu , Longjiang Li , Yunfeng Lin . Transdermal treatment for malignant melanoma by aptamer-modified tetrahedral framework nucleic acid delivery of vemurafenib. Chinese Chemical Letters, 2024, 35(4): 108602-. doi: 10.1016/j.cclet.2023.108602
5. [5]
  Haijun Shen , Yi Qiao , Chun Zhang , Yane Ma , Jialing Chen , Yingying Cao , Wenna Zheng . A matrix metalloproteinase-sensitive hydrogel combined with photothermal therapy for transdermal delivery of deferoxamine to accelerate diabetic pressure ulcer healing. Chinese Chemical Letters, 2024, 35(12): 110283-. doi: 10.1016/j.cclet.2024.110283
6. [6]
  Yingtao Zhong , Ziwen Qiu , Yanmei Li , Jiaqi Huang , Zhenming Lu , Renjiang Kong , Ni Yan , Hong Cheng . Nutrients deprivation of biomimetic nanozymes for cascade catalysis triggered and oxidative damage induced tumor eradication. Chinese Chemical Letters, 2025, 36(3): 109846-. doi: 10.1016/j.cclet.2024.109846
7. [7]
  Wenjuan Liu , Shanshan Zhang , Yu Wang , Bin Fang , Weirui Wang , Shujing Song , Tomohiro Hakozaki . Three-channel imaging reveals the comprehensive protein modifications and their impact on skin appearance induced by multiple stimuli. Chinese Chemical Letters, 2025, 36(6): 111182-. doi: 10.1016/j.cclet.2025.111182
8. [8]
  Makhloufi Zoulikha , Zhongjian Chen , Jun Wu , Wei He . Approved delivery strategies for biopharmaceuticals. Chinese Chemical Letters, 2025, 36(2): 110225-. doi: 10.1016/j.cclet.2024.110225
9. [9]
  Fengjie Liu , Fansu Meng , Zhenjiang Yang , Huan Wang , Yuehong Ren , Yu Cai , Xingwang Zhang . Exosome-biomimetic nanocarriers for oral drug delivery. Chinese Chemical Letters, 2024, 35(9): 109335-. doi: 10.1016/j.cclet.2023.109335
10. [10]
  Jialin Guo , Mingrui Gu , Yahui Chen , Tao Xiong , Yiyang Zhang , Simin Chen , Mingle Li , Xiaoqiang Chen , Xiaojun Peng . Nucleic acid delivery by lipid nanoparticles for organ targeting. Chinese Chemical Letters, 2025, 36(11): 110849-. doi: 10.1016/j.cclet.2025.110849
11. [11]
  Qin Yu , Haisheng He , Jianping Qi , Yi Lu , Wei Wu . Oral delivery of insulin by barbed microneedles actuated by intestinal peristalsis. Chinese Chemical Letters, 2024, 35(9): 109888-. doi: 10.1016/j.cclet.2024.109888
12. [12]
  Jing Zhang , Charles Wang , Yaoyao Zhang , Haining Xia , Yujuan Wang , Kun Ma , Junfeng Wang . Application of magnetotactic bacteria as engineering microrobots: Higher delivery efficiency of antitumor medicine. Chinese Chemical Letters, 2024, 35(10): 109420-. doi: 10.1016/j.cclet.2023.109420
13. [13]
  Yujie Li , Ya-Nan Wang , Yin-Gen Luo , Hongcai Yang , Jinrui Ren , Xiao Li . Advances in synthetic biology-based drug delivery systems for disease treatment. Chinese Chemical Letters, 2024, 35(11): 109576-. doi: 10.1016/j.cclet.2024.109576
14. [14]
  Weiyu Chen , Zenghui Li , Chenguang Zhao , Lisha Zha , Junfeng Shi , Dan Yuan . Enzyme-modulate conformational changes in amphiphile peptide for selectively cell delivery. Chinese Chemical Letters, 2024, 35(12): 109628-. doi: 10.1016/j.cclet.2024.109628
15. [15]
  Rui Li , Mengxi Zhu , Xiwen Hu , Jiaxuan Chen , Fei Yu , Stefan Barth , Lu Sun , Huining He . Overcoming endosomal/lysosomal barriers: Advanced strategies for cytosolic siRNA delivery. Chinese Chemical Letters, 2025, 36(9): 110736-. doi: 10.1016/j.cclet.2024.110736
16. [16]
  Shuwen Guo , Haipeng Xu , Zijun Cheng , Leyong Wang , Peng Yang , Ruibing Wang . Efficient cytosolic delivery of protein by preorganized amidiniums on pillar[5]arene. Chinese Chemical Letters, 2025, 36(10): 111022-. doi: 10.1016/j.cclet.2025.111022
17. [17]
  Jing Feng , Yanhong Liu , Liming Gong , Chenfei Liu , Congcong Xiao , Liqing Chen , Mingji Jin , Zhonggao Gao , Wei Huang , Yubo Li . Recent progress on drug delivery systems of regulating intratumoral bacteria for tumor therapy. Chinese Chemical Letters, 2025, 36(11): 110907-. doi: 10.1016/j.cclet.2025.110907
18. [18]
  Wen Xiao , Fazhan Wang , Yangzhuo Gu , Xi He , Na Fan , Qian Zheng , Shugang Qin , Zhongshan He , Yuquan Wei , Xiangrong Song . PEG400-mediated nanocarriers improve the delivery and therapeutic efficiency of mRNA tumor vaccines. Chinese Chemical Letters, 2024, 35(5): 108755-. doi: 10.1016/j.cclet.2023.108755
19. [19]
  Ningyue Xu , Jun Wang , Lei Liu , Changyang Gong . Injectable hydrogel-based drug delivery systems for enhancing the efficacy of radiation therapy: A review of recent advances. Chinese Chemical Letters, 2024, 35(8): 109225-. doi: 10.1016/j.cclet.2023.109225
20. [20]
  Qiang Li , Jiangbo Fan , Hongkai Mu , Lin Chen , Yongzhen Yang , Shiping Yu . Nucleus-targeting orange-emissive carbon dots delivery adriamycin for enhanced anti-liver cancer therapy. Chinese Chemical Letters, 2024, 35(6): 108947-. doi: 10.1016/j.cclet.2023.108947

Get Citation

PDF

XML

Metrics

PDF Downloads(1)
Abstract views(22)
HTML views(3)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142